Health product recall

JAMP-Cetirizine: Impurity

Last updated

Summary

Product
JAMP-Cetirizine
Issue
Health products - Product quality
What to do

See instructions below.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

JAMP-Cetirizine

JAMP-Cetirizine 10 mg

DIN 02451778

Tablet

Cetirizine Hydrochloride 10 mg

MC19004C

JAMP-Cetirizine

JAMP-Cetirizine 20 mg

DIN 02466171

Tablet

Cetirizine Hydrochloride 20 mg

MC20005B, MC20006

Issue

The impurities are out of specification in the affected lots. 

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers 

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Jamp Pharma Corporation.

1310 Nobel,

Boucherville, Quebec,

J4B 5H3

Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63567

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe